2m 2m 2m 2m 2m 2m 2m
LONGEVERON-A (LGVN)
NASDAQ
$0.63-$0.003 (-0.48%)
Price as of Jul 14, 2026 12:35 PM EDT- $19.0MMarket Cap
- -55.56%1-Year Change
- BiotechnologyIndustry
LONGEVERON-A (LGVN)
$0.63-$0.003 (-0.48%)
LGVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.63 | ||
Change | -$0.04 (-6.52%) | ||
Open | $0.69 | ||
High | $0.70 | ||
Low | $0.63 | ||
Previous Close | $0.68 | ||
Volume | 448,994 | ||
30-Day Average Volume | 306,616 | ||
1-Week Change | -2.85% | ||
1-Month Change | -19.37% | ||
1-Year Change | -55.56% | ||
3-Year Change | -98.12% | ||
5-Year Change | -99.15% | ||
Fundamentals | |||
Shares Outstanding | 30.1M | ||
Total Assets | $21.2M | ||
Market Cap | $19.0M | ||
Enterprise Value | $3.3M | ||
Period: QTR TTM FY | |||
Revenue | $378,000.00 | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$4.4M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $12.5M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/27/2024 | ||
Earnings & Revenue